Cargando…
Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy
Muscular dystrophy and dilated cardiomyopathy are intractable diseases and their treatment options are very limited. Transient receptor potential cation channel subfamily V, member 2 (TRPV2), is a stretch-sensitive Ca(2+)-permeable channel that causes sustained intracellular Ca(2+) increase in muscu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720432/ https://www.ncbi.nlm.nih.gov/pubmed/31394715 http://dx.doi.org/10.3390/ijms20163844 |